인쇄하기
취소

GC Pharm cruising to commercialize flu vaccine for the elderly

Published: 2018-08-06 09:32:18
Updated: 2018-08-06 09:32:46

GC Pharm has gotten a step closer to commercializing influenza vaccines that are more effective with the elderly.

GC Pharm(CEO Eun-Cheol Huh) announced on the 26th that they acquired approval of Phase II clinical trial for its high-volume quadrivalent influenza vaccine ‘GC3114’ from the Ministry of Food and Drug Safety(MFDS).

GC3114 is a product that has a better effect of preventing influenz...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.